Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-368285

Chief Executive Officer sold 18,921 shares at $49.57 ($937,957)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ceesay Abraham Chief Executive Officer 2026-08-25 Sale 10b5-1 −18,921 $49.57 $937,957 467,187 D
Open-market sales · 18,921 sh · avg $49.57 · $937,957
Loading xslF345X06/ownership.xml…